National randomised trial of hormone replacement therapy (HRT) in women with a history of early stage breast cancer

ISRCTN ISRCTN29941643
DOI https://doi.org/10.1186/ISRCTN29941643
ClinicalTrials.gov number NCT00079248
Secondary identifying numbers N/A
Submission date
01/07/2001
Registration date
01/07/2001
Last edited
28/01/2019
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

http://cancerhelp.cancerresearchuk.org/trials/a-trial-looking-at-hormone-replacement-therapy-for-women-who-have-had-treatment-for-breast-cancer

Contact information

Ms Lisa Lloyd
Scientific

Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)
Section of Epidemiology
Brookes Lawley Building
Cotswold Road
Sutton, Surrey
SM2 5NG
United Kingdom

Phone +44 (0)208 722 4063
Email lisa.lloyd@icr.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleNational randomised trial of hormone replacement therapy (HRT) in women with a history of early stage breast cancer
Study acronymHRT
Study hypothesisNot provided at time of registration
Ethics approval(s)Not provided at time of registration
ConditionBreast
Intervention1. HRT
2. No HRT (advice about non-hormonal alternatives)

Trial was closed early (December 2005) due to poor recruitment.
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/08/2003
Overall study end date01/08/2006
Reason abandoned (if study stopped)Participant recruitment issues

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexFemale
Target number of participantsModified 25/02/2010: 3000
Participant inclusion criteria1. Patients must have had proven stage I/II breast cancer with no clinical evidence of recurrence since diagnosis
2. Have been given a patient information pack
3. Be postmenopausal as defined by:
a. Having been amenorrhoeic for at least 6 months (including women who have had radiation or chemical induced ovarian suppression) irrespective of menopausal status at time of diagnosis
b. Having received surgical bilateral oophorectomy
c. Be experiencing vasomotor symptoms (i.e. hot flushes or night sweats) with or without vaginal dryness.

All such women are eligible irrespective of current/previous treatment for breast cancer.
Participant exclusion criteriaNot provided at time of registration
Recruitment start date01/08/2003
Recruitment end date01/08/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)
Sutton, Surrey
SM2 5NG
United Kingdom

Sponsor information

Individual Sponsor (UK)
Research organisation

C/o Mr Nigel Sacks
The Royal Marsden NHS Trust
London
SM2 5NG
United Kingdom

Phone +44 (0) 20 8722 4373
Email Claire.Dawson@icr.ac.uk
Website http://www.cancer.org.uk

Funders

Funder type

Charity

Cancer Research UK
Private sector organisation / Other non-profit organizations
Alternative name(s)
CR_UK, Cancer Research UK - London, CRUK
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

28/01/2019: No publications found, verifying results with the principal investigator